Investing Profile

Cory Freedland

InvestorVC

Principal at Samsara BioCapital

samsaracap.com/cory-freedland...San Francisco Bay Area
Photo of Cory Freedland, Principal at Samsara BioCapital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$1M - $100.0M
$25.0M
2
$310.1M
CompanyStageDateRound SizeTotal Raised
Palvella Therapeutics
Series CMay 2020$45M
$45M
Velicept Therapeutics
Series BOct 2018$15M
$15M